[ET Net News Agency, 14 July 2025] AKESO (09926) rose 4.5% to HK$118.3.
It hits an intra-day high of HK$118.3, hitting a historical high, and an intra-day low of HK$112.6. The total shares traded was 7.24 million, with a value of HK$834.88m. The active buy/sell ratio is 58:42, with net buying turnover of HK$125.71m. CHINA INT'L CAPITAL CORP HK accounts for greatest net responsive buying turnover of HK$11.66m, with volume weighted average price of HK$115.151. BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$35.42m, with volume weighted average price of HK$115.616. The stock has risen a combined 9.2% over the past 2 consecutive trading days.
Basic Information| Nominal | 118.300 | % Chg | +4.51% |
| High | 118.300 | Low | 112.600 |
| Shares Tr | 7.24m | Turnover | 834.88m |
| 10-D SMA | 107.935 | %H.V | 69.304 |
| 20-D SMA | 101.428 | VWAP | 115.362 |
| 50-D SMA | 91.501 | RSI14 | 70.137 |
Status: Hitting a historical high, active buy/sell ratio is 58:42, with net buying turnover of HK$125.71m, rising a combined 9.2% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| AKESO (09926) | 118.30 | +4.51 |
| SINO BIOPHARM (01177) | 6.00 | +1.18 |
| 3SBIO (01530) | 27.70 | +10.14 |
| EVEREST MED (01952) | 71.85 | +6.13 |
| WUXI XDC (02268) | 48.45 | +5.33 |
| ASCENTAGE-B (06855) | 75.75 | -0.79 |
| SKB BIO-B (06990) | 340.40 | +0.12 |
| ZAI LAB (09688) | 26.70 | +1.91 |
| INNOCARE (09969) | 16.40 | +2.76 |
| REMEGEN (09995) | 64.65 | +2.29 |
(ed)
Nominal 